TEST:

gen-TRU-breast™ Assay

genTRU-breast, a state-of-the-art real-time qPCR assay, is designed to detect early-stage breast cancer with unparalleled precision. This assay hinges on the quantification of messenger RNA (mRNA) expression profiles of proprietary gene targets, offering a powerful tool for the identification of breast cancer at its earliest, most treatable stages. The technology is based on the dynamic response of the patient, as opposed to the detection of circulating cancer cells.